Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL

The latest guidelines from the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) proposed a new "extreme-risk" category of patients, for whom a low-density lipoprotein cholesterol (LDL-C) level

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2018-08, Vol.275, p.262-264
Main Authors: Rallidis, Loukianos S., Kiouri, Estela, Katsimardos, Andreas, Kotakos, Christos
Format: Article
Language:English
Subjects:
Coronary artery disease
Extreme risk category
LDL cholesterol target
PCSK9-Inhibitor
Statins
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The latest guidelines from the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) proposed a new "extreme-risk" category of patients, for whom a low-density lipoprotein cholesterol (LDL-C) level
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2018.06.821